Evidence map›Paper›PMID 38940916›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2024

Proteolytic degradation of atrial sarcomere proteins underlies contractile defects in atrial fibrillation.

Hannah E Cizauskas, Hope V Burnham, Azaria Panni, Alexandra Peña, Alejandro Alvarez-Arce, M Therese Davis, Kelly N Araujo, Christine E Delligatti, Seby Edassery, Jonathan A Kirk and 2 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Evidence for a role of adverse sarcomere signaling in atrial fibrillation induction.Journal of molecular and cellular cardiology plus · 2026
    Review
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Hannah E CizauskasDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.
Hope V BurnhamDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.ORCID 0000-0001-9912-019X
Azaria PanniFeinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Alexandra PeñaDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.
Alejandro Alvarez-ArceDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.ORCID 0000-0001-9608-3004
M Therese DavisDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.
Kelly N AraujoDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.
Christine E DelligattiDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.
Seby EdasseryDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.ORCID 0000-0003-1129-748X
Jonathan A KirkDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.ORCID 0000-0002-5192-2860
Rishi AroraFeinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
David Y BarefieldDepartment of Cell and Molecular Physiology, Loyola University Chicago, Chicago, Illinois, United States.ORCID 0000-0002-6166-640X

Funding

New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial FibrillationR35HL161249 · NHLBI · UNIVERSITY OF CHICAGO · PI Rishi Arora · 2022 to 2026
$5.1M
GSK-3β Localizes to the Myofilament and Modifies its Function in Ischemic CardiomyopathyR01HL136737 · NHLBI · UNIVERSITY OF CHICAGO · PI JONATHAN A KIRK · 2017 to 2026
$4.5M
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heartR01HL152712 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARORA, RISHI, ZHAO, MING · 2021 to 2024
$3.0M
Broadly applicable high throughput variant interpretation and validation for MYH7R01HL175964 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI JONATHAN A KIRK, Md. Abul Hassan Samee · 2024 to 2026
$2.1M
Structural and functional basis of myocardial dysregulation in genetic cardiomyopathyR01HL172492 · NHLBI · UNIVERSITY OF CHICAGO · PI THOMAS C IRVING, JONATHAN A KIRK · 2024 to 2026
$2.1M
Myofilament proteins in cardiomyopathy and arrhythmiasR00HL141698 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI BAREFIELD, DAVID Y · 2020 to 2022
$747k
Regulation of atrial contractility in cardiomyopathyR56HL165137 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI BAREFIELD, DAVID Y · 2022 to 2022
$597k
American Heart Association (AHA) 23POST1023125HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 141698HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 161249HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 165137NHLBI NIH HHS R00 HL141698NHLBI NIH HHS R01 HL136737NHLBI NIH HHS R01 HL152712NHLBI NIH HHS R35 HL161249NHLBI NIH HHS R56 HL165137
6 · The paper itself

Abstract

Atrial fibrillation (AFib) is the most common cardiac rhythm disturbance, often treated via electrical cardioversion. Following rhythm restoration, a period of depressed mechanical function known as atrial stunning occurs, suggesting that defects in contractility occur in AFib and are revealed upon restoration of rhythm. This project aims to define the contractile remodeling that occurs in AFib. To assess contractile function, we used a canine atrial tachypacing model of induced AFib. Mass spectrometry analysis showed dysregulation of contractile proteins in samples from AFib compared with sinus rhythm atria. Atrial cardiomyocytes show reduced force of contraction, decreased resting tension, and increased calcium sensitivity in skinned single cardiomyocyte studies. These alterations correlated with degradation of myofilament proteins including myosin heavy chain altering force of contraction, titin altering resting tension, and troponin I altering calcium sensitivity. We measured degradation of other myofilament proteins, including cardiac myosin binding protein C and actinin, that show degradation products in the AFib samples that are absent in the sinus rhythm atria. Many of the degradation products appeared as discrete cleavage products that are generated by calpain proteolysis. We assessed calpain activity and found it to be significantly increased. These results provide an understanding of the contractile remodeling that occurs in AFib and provide insight into the molecular explanation for atrial stunning and the increased risk of atrial thrombus and stroke in AFib.

Indexed as

Atrial FibrillationHeart AtriaMyocardial ContractionMyocytes, CardiacProteolysisSarcomeresAnimalsCalpainDisease Models, AnimalDogsMaleCalpainatrial contractilityatrial fibrillationatrial myofilamentatrial stunningcalpain proteolysis

Identifiers

PMID38940916
PMCPMC11442024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.